- Home
- SURVANTA INJECTION 4ML
SURVANTA INJECTION 4ML Substitute
SURVANTA INJECTION 4ML Substitute
Verified Ingredients and Effects
Composition:
BERACTANT-25MG
Uses:
<p>SURVANTA INJECTION 4ML is used in the treatment of Respiratory distress syndrome (RDS). The detailed uses of SURVANTA INJECTION 4ML are as follows:</p><ul><li><strong>Prevention of Respiratory Distress Syndrome (RDS):</strong> SURVANTA INJECTION 4ML is administered to premature infants at high risk of developing RDS. It acts as a pulmonary surfactant, helping the lungs stay expanded and improving oxygen exchange by reducing surface tension in the alveoli.</li><li><strong>Treatment of established RDS:</strong>SURVANTA INJECTION 4ML is also used in new borns who have already developed RDS. It helps stabilize breathing and reduces the need for mechanical ventilation by enhancing lung compliance and gas exchange.</li></ul>
Medicinal Benefits:
SURVANTA INJECTION 4ML contains Beractant as a natural surfactant. SURVANTA INJECTION 4ML is used to treat respiratory distress syndrome (RDS) in newborn premature infants weighing 700 g or more at delivery. It is also used to treat premature babies who are in danger of developing RDS and require a tube put into their windpipe for stabilisation or who have indications of surfactant deficiency. It functions similarly to your baby's own surfactant, assisting your infant in breathing healthily. It will allow your infant to breathe normally until his or her own surfactant is produced.
FAQs
SURVANTA INJECTION 4ML is used to treat Respiratory distress syndrome (RDS).
SURVANTA INJECTION 4ML contains Beractant, a natural surfactant that acts similarly to your baby’s surfactant, helping your baby breathe normally. It will help your baby breathe normally until it produces its own surfactant.
No, it is not necessary to use SURVANTA INJECTION 4ML in all premature babies. It should be used only in premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS).
SURVANTA INJECTION 4ML can be used in those whose pregnancy lasted less than 32 weeks, whose infants are in danger of developing RDS and require a tube put into the windpipe for stabilisation, or who have indications of surfactant deficiency.
SURVANTA INJECTION 4ML is administered via a breathing tube to the lungs by a medical professional with specialized training in a hospital. Consult your paediatrician about the use of this medication in young patients. This medicine is not for injection.
